Board of Directors

2008 BOARD OF DIRECTORS

EXECUTIVE COMMITTEE/OFFICERS

Mr. Ronnie Miller, Chairman of the Board
President & CEO, Hoffmann-La Roche Limited

Mr. Arnout Ploos van Amstel, First Vice-Chair
President and Managing Director, Wyeth Pharmaceuticals

Ms. Dawn Graham, Second Vice-Chair
President, Merck Frosst Canada

Mr. Paul Lévesque, Treasurer
President & CEO, Pfizer Canada Inc.

Dr. Philippe Calais, Executive Committee member representing Biopharmaceutical Members
President & CEO, Ambrilia Biopharma Inc.

Mr. Philip Blake, Immediate Past-Chair
President & CEO, Bayer Inc.

Mr. Russell Williams, President
Canada’s Research-Based Pharmaceutical Companies (Rx&D)

DIRECTORS

Ms. Deborah M. Brown
Regional Vice President & General Manager, EMD Serono Canada Inc.

Mr. Carlos Dourado
President & General Manager, Schering-Plough Canada Inc.

Mr. Chris Halyk
President, Janssen-Ortho Inc.

Mr. Graham Jobson
President & CEO, Solvay Pharma Inc.

Mr. Mark S. Jones
President & CEO, AstraZeneca Canada Inc.

Mr. Paul Lucas
President & CEO, GlaxoSmithKline Inc.

Mr. Andy McClenaghan
General Manager, Procter & Gamble Pharmaceuticals Canada Inc.

Mr. David Meek
President, Novartis Pharmaceuticals Canada Inc.

Mr. David Ricks
President & General Manager, Eli Lilly Canada Inc.

Mr. Jérôme Silvestre
President, sanofi-aventis Canada

Mr. John Stewart
President & CEO, Purdue Pharma

Mr. John Suk
President & CEO, Nycomed Canada Inc.

Mr. Michael Sumpter
Chief Executive Officer, Servier Canada Inc.

Revised April 28th, 2008